Placebo (0.5 ml)

DRUG2 trials

Sponsors

Biozeus Biopharmaceutical S.A.

Conditions

Female Sexual Arousal DisorderFemale Sexual DysfunctionFemale Sexual Dysfunction (FSD)

Phase 2

Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder

RecruitingNCT06116045

Biozeus Biopharmaceutical S.A.Female Sexual Arousal Disorder, Female Sexual Dysfunction

Start: 2024-10-01End: 2025-03-31Target: 30Updated: 2024-10-22

Evaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder

Not yet recruitingNCT06651541

Biozeus Biopharmaceutical S.A.Female Sexual Arousal Disorder, Female Sexual Dysfunction (FSD)

Start: 2026-07-01End: 2027-07-31Target: 174Updated: 2025-11-17